We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Examination of the Therapeutic Potential of Delta-24-RGD in Brain Tumor Stem Cells: Role of Autophagic Cell Death.
- Authors
Hong Jiang; Gomez-Manzano, Candelaria; Aoki, Hiroshi; Alonso, Marta M.; Kondo, Seiji; McCormick, Frank; Jing Xu; Kondo, Yasuko; Bekele, B. Nebiyou; Colman, Howard; Lang, Frederick F.; Fueyo, Juan
- Abstract
The eradication of brain tumor stem cells is essential for long-term brain tumor remission after treatment. In this study, we examined the therapeutic potential of an oncolytic adenovirus, Delta-24-RGD, targeted to the abnormal p16INK4/Rb pathway in brain tumor stem cells. Four brain tumor stem cell lines from surgical glioblastonia specimens expressed high levels of adenoviral receptors and allowed for efficient viral infection, replication, and oncolysis in an Rb-dependent manner. Delta-24-RGD induced autophagic cell death, as indicated by accumulation of Atg5 and LC3-II protein and autophagic vacuoles. Treatment of xenografts derived from brain tumor stem cells with Delta-24-RGD statistically significantly improved the survival of glioma-bearing mice (means: 38.5 versus 66.3 days, difference = 27.8 days, 95% confidence interval = 19.5 to 35.9 days, P<.001). Analyses of treated tumors showed that Atg5 expression colocalized with viral fiber protein and delineated a wave front of autophagic cells that circumscribed areas of virally induced necrosis. Our results show for the first time that brain tumor stem cells are susceptible to adenovirus-mediated cell death via autophagy in vitro and in vivo.
- Subjects
BRAIN cancer; STEM cells; TUMORS; CELL death; DEATH (Biology)
- Publication
JNCI: Journal of the National Cancer Institute, 2007, Vol 99, Issue 18, p1410
- ISSN
0027-8874
- Publication type
Article
- DOI
10.1093/jnci/djm102